The level of the soluble form of CD93 in plasma was significantly 30 % lower in the CRC patients (mean, 129.7; SD, 55.74 ng/mL) compared to the controls (mean, 186.0; SD, 74.47 ng/mL) (P < 0.001) (Fig. 4). Here, CD93 is linked to colorectal carcinoma.